In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
(00:00) Introduction
(00:50) Backdrop of private markets and introduction to biotech
(04:34) Challenges and opportunities in biotech
(07:35) M&A
(09:58) Market themes
(14:50) Valuations
(16:25) Closing remarks
6 окт 2024
